The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Voskresenskaya A.A.

Cheboksary branch of the S.N. Fedorov National Medical Research Center “MNTK “Eye Microsurgery”;
Postgraduate Doctors’ Training Institute

Sarkizova M.B.

S.N. Fedorov National Medical Research Center “MNTK “Eye Microsurgery”

Khodzhaev N.S.

S.N. Fedorov National Medical Research Center “MNTK “Eye Microsurgery”

Kudlay D.A.

I.M. Sechenov First Moscow State Medical University (Sechenov University);
Lomonosov Moscow State University;
JSC GENERIUM

Kakunina S.A.

S.N. Fedorov National Medical Research Center “MNTK “Eye Microsurgery”

Borozinets A.Yu.

JSC GENERIUM

Pozdeyeva N.A.

Cheboksary branch of the S.N. Fedorov National Medical Research Center “MNTK “Eye Microsurgery”;
Postgraduate Doctors’ Training Institute

Biosimilars of ranibizumab in retinal diseases: new possibilities in ophthalmology

Authors:

Voskresenskaya A.A., Sarkizova M.B., Khodzhaev N.S., Kudlay D.A., Kakunina S.A., Borozinets A.Yu., Pozdeyeva N.A.

More about the authors

Journal: Russian Annals of Ophthalmology. 2025;141(2): 106‑116

Read: 362 times


To cite this article:

Voskresenskaya AA, Sarkizova MB, Khodzhaev NS, Kudlay DA, Kakunina SA, Borozinets AYu, Pozdeyeva NA. Biosimilars of ranibizumab in retinal diseases: new possibilities in ophthalmology. Russian Annals of Ophthalmology. 2025;141(2):106‑116. (In Russ.)
https://doi.org/10.17116/oftalma2025141021106

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.